SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 139 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,661,000 | +24.9% | 110,729 | 0.0% | 0.02% | +41.7% |
| Q2 2022 | $2,130,000 | +10.7% | 110,729 | 0.0% | 0.01% | +9.1% |
| Q1 2022 | $1,924,000 | -20.6% | 110,729 | 0.0% | 0.01% | -8.3% |
| Q4 2021 | $2,424,000 | +14.6% | 110,729 | 0.0% | 0.01% | +33.3% |
| Q3 2021 | $2,116,000 | – | 110,729 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 1,843,388 | $27,208,000 | 5.07% |
| Aisling Capital Management LP | 1,025,000 | $15,129,000 | 4.83% |
| BVF INC/IL | 2,470,678 | $36,467,000 | 1.99% |
| Ghost Tree Capital, LLC | 425,000 | $6,273,000 | 1.81% |
| VR Adviser, LLC | 625,710 | $9,235,000 | 1.81% |
| FRAZIER MANAGEMENT LLC | 1,320,045 | $19,484,000 | 1.75% |
| Avidity Partners Management LP | 1,854,100 | $27,367,000 | 1.27% |
| Boxer Capital, LLC | 2,287,782 | $33,768,000 | 1.17% |
| ACUTA CAPITAL PARTNERS, LLC | 240,744 | $3,553,000 | 0.96% |
| 683 Capital Management, LLC | 828,371 | $12,227,000 | 0.90% |